Frequency and Nature of Generic "Design Around" of Brand‐Name Patents in the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 190, doi. 10.1002/cpt.3659
- By:
- Publication type:
- Article
Works matching DE "GENERIC products"
Results: 432
1
2
Antimicrobial drug-nutrition interactions: Consistency of information for generic drugs.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2020, v. 77, n. 10, p. 1073, doi. 10.2298/VSP181002191N
- By:
- Publication type:
- Article
3
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
4
Dynamic competition in pharmaceuticals: Patent expiry, generic penetration, and industry structure.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 175, doi. 10.1007/s10198-003-0218-x
- By:
- Publication type:
- Article
5
Building a Dangerous Outpost in the Green Mountain State: A Case Study of Educator Preparation Policymaking.
- Published in:
- Education Policy Analysis Archives / Archivos Analíticos de Políticas Educativas / Arquivos Analíticos de Políticas Educativas, 2018, v. 26, n. 32-37, p. 1, doi. 10.14507/epaa.26.2848
- By:
- Publication type:
- Article
6
Continuous gluconic acid production by the yeast-like Aureobasidium pullulans in a cascading operation of two bioreactors.
- Published in:
- Applied Microbiology & Biotechnology, 2006, v. 73, n. 3, p. 541, doi. 10.1007/s00253-006-0499-y
- Publication type:
- Article
7
EGAD: ultra-fast functional analysis of gene networks.
- Published in:
- Bioinformatics, 2017, v. 33, n. 4, p. 612, doi. 10.1093/bioinformatics/btw695
- By:
- Publication type:
- Article
8
COMPARATIVE QUALITY CONTROL STUDIES ON THREE BRANDS OF METFORMIN HYDROCHLORIDE TABLETS MARKETED IN KADUNA, NIGERIA.
- Published in:
- Journal of Pharmaceutical & Allied Sciences, 2019, v. 16, n. 4, p. 3086
- By:
- Publication type:
- Article
9
Post‐marketing assessment of generic tamoxifen in Brazilian breast cancer patients.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, n. 5, p. 432, doi. 10.1111/bcpt.13368
- By:
- Publication type:
- Article
10
Voluntary licensing of long-acting HIV prevention and treatment regimens: using a proven collaboration- and competition-based mechanism to rapidly expand at-scale, sustainable, quality-assured and affordable supplies in LMICs.
- Published in:
- Journal of the International AIDS Society, 2023, v. 26, p. 76, doi. 10.1002/jia2.26092
- By:
- Publication type:
- Article
11
Biogenerics 2007: How far have we come?
- Published in:
- Journal of Commercial Biotechnology, 2008, v. 14, n. 1, p. 56, doi. 10.1057/palgrave.jcb.3050080
- By:
- Publication type:
- Article
12
Legal and regulatory update.
- Published in:
- Journal of Commercial Biotechnology, 2005, v. 11, n. 2, p. 176, doi. 10.1057/palgrave.jcb.3040115
- Publication type:
- Article
13
Therapies Out of Reach: Anticancer Drugs and Global Trade Regimes.
- Published in:
- Science Technology & Society, 2018, v. 23, n. 3, p. 371, doi. 10.1177/0971721818762909
- By:
- Publication type:
- Article
14
What's in a name? Use of brand versus generic drug names in United States outpatient practice.
- Published in:
- 2007
- By:
- Publication type:
- journal article
15
Badania porównawcze niektórych preparatów zawierających itrakonazol w oparciu o wybrane dane fizykochemiczne i farmakokinetyczne.
- Published in:
- Medical Mycology / Mikologia, 2007, v. 14, n. 1, p. 15
- By:
- Publication type:
- Article
16
Czy lek generyczny daje ten sam efekt terapeutyczny Co lek oryginalny? Głos w dyskusji.
- Published in:
- Medical Mycology / Mikologia, 2007, v. 14, n. 1, p. 9
- By:
- Publication type:
- Article
17
Distinctively Similar: A Generic Problem.
- Published in:
- 2013
- By:
- Publication type:
- Essay
18
2013 TRADEMARK LAW DECISIONS OF THE FEDERAL CIRCUIT.
- Published in:
- American University Law Review, 2014, v. 63, n. 4, p. 1419
- By:
- Publication type:
- Article
19
News In Brief.
- Published in:
- Nature Medicine, 2004, v. 10, n. 12, p. 1269, doi. 10.1038/nm1204-1269
- Publication type:
- Article
20
Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs.
- Published in:
- Dose-Response, 2020, v. 18, n. 1, p. 1, doi. 10.1177/1559325820908980
- By:
- Publication type:
- Article
21
Regulatory framework and disparities of complex generics in United States, European Union & Latin America.
- Published in:
- Journal of Generic Medicines, 2023, v. 19, n. 3, p. 130, doi. 10.1177/17411343231194755
- By:
- Publication type:
- Article
22
Developing a structural equation model for the life cycle of generic pharmaceutical products.
- Published in:
- Journal of Generic Medicines, 2022, v. 18, n. 3, p. 176, doi. 10.1177/17411343221076744
- By:
- Publication type:
- Article
23
Retrospective analysis of drug utilization and rational drug use in treatment of essential arterial hypertension in Bulgaria: Generic perception.
- Published in:
- Journal of Generic Medicines, 2022, v. 18, n. 2, p. 88, doi. 10.1177/17411343211055896
- By:
- Publication type:
- Article
24
Comparison of generic drug registration strategies between health Canada and Gulf Cooperation Council.
- Published in:
- Journal of Generic Medicines, 2022, v. 18, n. 2, p. 82, doi. 10.1177/17411343211029995
- By:
- Publication type:
- Article
25
Brand drug companies impeding generic drug company access to product samples: Estimated prevalence and impact on drug costs.
- Published in:
- Journal of Generic Medicines, 2022, v. 18, n. 1, p. 10, doi. 10.1177/17411343211035168
- By:
- Publication type:
- Article
26
Comparison of regulatory dossier requirements for marketing authorization of generic solid dosage forms in the United States and Europe: A review.
- Published in:
- Journal of Generic Medicines, 2021, v. 17, n. 4, p. 174, doi. 10.1177/17411343211000788
- By:
- Publication type:
- Article
27
Editorial.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
28
Generic drugs, a need to the public: USA and India - Government plans to reduce the price of abbreviated new drug application and list of generic drugs approved in year 2018.
- Published in:
- Journal of Generic Medicines, 2019, v. 15, n. 3, p. 115, doi. 10.1177/1741134319848811
- By:
- Publication type:
- Article
29
Deficiencies in generic product dossiers as submitted to the WHO Prequalification of Medicines Programme.
- Published in:
- Journal of Generic Medicines, 2012, v. 9, n. 2, p. 63, doi. 10.1177/1741134312448062
- By:
- Publication type:
- Article
30
The role of generic medicines in the Portuguese crisis.
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 4, p. 204, doi. 10.1177/1741134311428695
- By:
- Publication type:
- Article
31
Opportunities and challenges to implementing Quality by Design approach in generic drug development.
- Published in:
- Journal of Generic Medicines, 2010, v. 7, n. 1, p. 60, doi. 10.1057/jgm.2009.37
- By:
- Publication type:
- Article
32
Mergers & Acquisitions update: Changing the strategic paradigm in the global generics market.
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 4, p. 315, doi. 10.1057/jgm.2009.21
- By:
- Publication type:
- Article
33
A follow-on biological drug is not a biogeneric: Lessons from Omnitrope and Valtropin.
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 3, p. 237, doi. 10.1057/jgm.2009.8
- By:
- Publication type:
- Article
34
Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia.
- Published in:
- Journal of Generic Medicines, 2008, v. 6, n. 1, p. 35, doi. 10.1057/jgm.2008.25
- By:
- Publication type:
- Article
35
Developing the Japanese generic medicines market: What can we learn from Europe?
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 2, p. 129, doi. 10.1057/jgm.2009.4
- By:
- Publication type:
- Article
36
Innovation through generic medicines: Is it time for a pan-European policy?
- Published in:
- Journal of Generic Medicines, 2008, v. 6, n. 1, p. 3, doi. 10.1057/jgm.2008.30
- By:
- Publication type:
- Article
37
A buyer's guide to generic pharmaceutical acquisitions.
- Published in:
- Journal of Generic Medicines, 2008, v. 6, n. 1, p. 9, doi. 10.1057/jgm.2008.28
- By:
- Publication type:
- Article
38
Biological generics: A business case.
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 3, p. 186, doi. 10.1057/palgrave.jgm.4950067
- By:
- Publication type:
- Article
39
Common pitfalls and issues during generic licensing negotiations.
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 3, p. 180, doi. 10.1057/palgrave.jgm.4950069
- By:
- Publication type:
- Article
40
Generic biotech.
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 3, p. 159, doi. 10.1057/palgrave.jgm.4950070
- By:
- Publication type:
- Article
41
The Citizen Petition: For the public good or brands behaving badly?
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 2, p. 87, doi. 10.1057/palgrave.jgm.4950060
- By:
- Publication type:
- Article
42
What is the value of authorised generic agreements? Assessments on the French market.
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 2, p. 106, doi. 10.1057/palgrave.jgm.4950061
- By:
- Publication type:
- Article
43
Strategic options for mid-sized generics players.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 4, p. 308, doi. 10.1057/palgrave.jgm.4940083
- By:
- Publication type:
- Article
44
Meeting the challenge of growth and profitability.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 4, p. 297, doi. 10.1057/palgrave.jgm.4940082
- By:
- Publication type:
- Article
45
Comprehensive characterisation of the innovator product: Targeting bioequivalent generics.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 4, p. 335, doi. 10.1057/palgrave.jgm.4940086
- By:
- Publication type:
- Article
46
EU Legal and Regulatory Update.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 2, p. 173, doi. 10.1057/palgrave.jgm.4940067
- Publication type:
- Article
47
The EU regulatory environment for 'biosimilars': Today's picture and future prospects.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 2, p. 111, doi. 10.1057/palgrave.jgm.4940059
- By:
- Publication type:
- Article
48
An overview of the scientific and regulatory issues facing biogenerics in the USA today.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 2, p. 169, doi. 10.1057/palgrave.jgm.4940066
- Publication type:
- Article
49
Strategies for biogeneric success.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 2, p. 145, doi. 10.1057/palgrave.jgm.4940063
- By:
- Publication type:
- Article
50
Scientific issues for biogenerics/biosimilars.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 2, p. 125, doi. 10.1057/palgrave.jgm.4940061
- By:
- Publication type:
- Article